CorneaGen

CorneaGen is the largest provider of corneal transplant tissue in the United States, holding 25% market share. Established in 2016 and headquartered in Seattle, the company delivered over 32,500 sight-restoring grafts in 2023 to the US and 50 other countries. CorneaGen operates regional laboratories processing tens of thousands of corneas weekly, meeting FDA and Eye Bank Association of America standards. The company offers a comprehensive portfolio of corneal tissue products and surgical devices, including the EndoSerter®-PL (a pre-loaded instrument for DSEK), Geuder Pre-Loaded Glass Cannula for DMEK, CTAK (customized corneal tissue inlays for keratoplasty), VisionGraft®, and Intacs® Corneal Implants. CorneaGen serves ophthalmologists and corneal surgeons globally, providing customized processed tissue for standard and complicated cases, along with surgeon education programs, training resources, and advocacy for patient access to corneal care.